Coenzyme Q10 (Ubiquinone)
Coenzyme Q10 is a fat-soluble compound central to mitochondrial energy production and a lipid-phase antioxidant. PED users take it for general cardiovascular and cellular support, and specifically to offset the fall in CoQ10 levels that statins cause. Human evidence is strongest for the statin-depletion rationale and heart failure, and weaker for most other claimed benefits.
01 Overview
CoQ10 shuttles electrons in the mitochondrial respiratory chain and protects membranes and LDL particles from oxidation. Statins reduce endogenous CoQ10 synthesis because it shares the mevalonate pathway with cholesterol, which is the mechanistic basis for supplementing it alongside statin therapy — though whether this reliably reduces statin-associated muscle symptoms remains debated in trials.
Among PED users CoQ10 is taken for cardiovascular support during cycles, often together with a statin or in the context of raised blood pressure and cardiac workload. It is very well tolerated. Framed honestly, the supplement is biologically plausible and low-risk, but hard clinical benefit outside heart failure and statin-depletion contexts is not well established.
02 Mechanism
Essential electron carrier in the mitochondrial respiratory chain and a lipid-soluble antioxidant; its synthesis shares the mevalonate pathway blocked by statins.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| General / statin support | 100–200 mg/day | Oral | Taken with a fat-containing meal for absorption. |
| Higher supplemental use | 200–400 mg/day | Oral | Upper range used in heart-failure studies and by some users on statins. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Replenishes statin-lowered CoQ10Raises circulating CoQ10 reduced by statin therapy; symptomatic benefit for statin myalgia is debated. | restores levels | Observational | |
| Possible heart-failure benefitSome trials suggest symptomatic benefit in heart failure; not directly applicable to healthy cycle users. | modest | Observational |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Mild GI upsetOccasional nausea or stomach discomfort at higher doses. | Mild | Uncommon | Observational | |
| Anticoagulant interactionMay slightly reduce the effect of warfarin due to structural similarity to vitamin K. | Mild | Rare | Anecdotal |